After seven years of planning, Bioscience 2, a collaboration between University of Colorado Anschutz Medical Campus and Fitzsimons Redevelopment Authority (FRA), will hold its grand opening today.
The event will include brief remarks, an opportunity to participate in interactive research demonstrations and tours of the state-of-the-art bioengineering department.
“The building is designed for education, research and commercialization,” said Robin Shandas, PhD, associate professor and chairman of the bioengineering department at CU Anschutz and CU Denver. “Bioscience 2 truly embodies the concept of bringing research from the `bench to the patient’s bedside.’’’
The new 112,000 square foot building will accommodate approximately 250 students and provide space for bioscience companies. The addition of Bioscience 2 allowed CU Anschutz Medical Campus organizations to expand and continue growing their innovative programs. These organizations include ClinImmune Labs and University of Colorado Cord Blood Bank (UCCBB) and iC42, one of University of Colorado Anschutz’s many core labs that provide services to University faculty and commercial entities. Along with the benefits of having access to CU Anschutz researchers and faculty, the new facility boasts clinical specimen freezers for all of the campus laboratory services and four cGMP clean rooms.
“This new facility encourages growth and partnerships between academic and commercial entities that will contribute to the Fitzsimons Innovation Campus’ objective of continuing to provide opportunities for rapid growth of the life science industry in Colorado,” said Steve VanNurden, president and CEO of the FRA.